Concise Info

Manufacturer Info

Isoxilan - Concise Prescribing Information

> Manufacturer > Distributor > Contents > Indications > Dosage > Administration > Contraindications > Special Precautions > Adverse Drug Reactions > Drug Interactions > Pregnancy Category (US FDA) > MIMS Class > ATC Classification > Poison Schedule > Presentation/Packing

Related Information

See related Isoxilan informationAbbreviation Index Manufacturer Distributor Contents Indications BioFemme United Lab Isoxsuprine HCl Uterine hypermotility disorders: Threatened abortion, premature labor & dysmenorrhea. An adjunct therapy in the treatment of arteriosclerosisobliterans, thromboangitis obliterans (Buerger's disease) & Raynaud's disease. Uterine hypermotility 100 mg in 500 mL infusion fluid w/ IV infusion rate of 1-1.5 mL/min up to 2.5 mL/min until control is maintained. If IV infusion is not feasible, 10 mg IM (2 mL amp) every 3 hr for 24 hr then every 4-6 hr for 48 hr. Maintenance: 2 tab qid when contractions have ceased for 48 hr.Circulatory disturbances Adult 2 tab tid-qid, or 5-10 mg IM (1-2 mL) up to tid. May be taken with or without food (May be taken w/ meals, milk or antacids to minimise GI discomfort.).

Dosage

Administration

Contraindications Following arterial hemorrhage, CV disease & severe anemia. Hypotension, tachycardia, premature detachment of the placenta & premature labor w/ infection. Special Precautions Adverse Drug Reactions In uterine hypermotility, do not use large vol of fluid to prevent fluid overload. Monitor BP & heart rate. Hypotension, tachycardia, palpitations, dizziness & flushing. May cause slight increase in fetal heart rate if used as IV infusion in premature labor. View ADR Monitoring Website

Drug Interactions Other vasodilators & antihypertensive drugs. View more drug interactions with Isoxilan Pregnancy Category (US FDA)

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. Peripheral Vasodilators & Cerebral Activators / Drugs Acting on the Uterus C04AA01 - isoxsuprine ; Belongs to the class of 2-amino-1-phenylethanol derivative agents. Used as peripheral vasodilators. Rx

MIMS Class ATC Classification Poison Schedule

Presentation/Packing Form Isoxilan tablet Isoxilan injection Manufacturer: BioFemme Distributor: United Lab Related Isoxilan information: Drugs interacting with Isoxilan Find Isoxilan in other countries Search Isoxilan in Google Search Isoxilan in PubMed

Packing/Price Isoxilan 10 mg x 100's (P1448) Isoxilan (amp) 10 mg/2 mL x 5's (P525)

Photo

Interaction Checker Pill Identifier Browse Drugs A-Z Browse Companies Browse MIMS Class Browse Diagnoses Browse Calculators Medical Tribune JPOG MIMS Publications MIMS Integrated Medical Events Useful Links

Latest News

Highlights

Drug Updates

New Molecule

New Formulations

Prime Links

Featured Drugs

Is there a role for LH in controlled ovarian stimulation?

Amoclav Avamax Carvid Claritin Exigo Micotran Omnaris Plogrel Sevo Skelan Steinbach Silymarin... Supraneuron Tascit Zenith

Read Medical Tribune

Read JPOG

Browse MIMS.com
Drugs

Events
GWICC The 22nd Great Wall International Congress of Cardiology & Asia Pacific Heart Congress 2011 APSR 2011 16th Congress of the Asian Pacific Society of Respirology East Meets West Hong Kong Diabetes & Cardiovascular Risk Factors East Meets West (EMW) Symposium The Primary Care Clinic Multi-disciplinary CME programme for Asian physicians Medical Progress CPD - Malaysia Medical Progress Continuing Professional Development

Asia-Pacific Resources
KIMS OnLine Korea drug search engine Medical Observer Australian medical news online Pharmacy Today New Zealand pharmacists' online resource

International Resources
CancerNetwork Oncology news and resources ConsultantLive.com US physicians medical news and updates OBGYN.net Obstetrics & gynecology online resource centre Psychiatric Times Psychiatry news and resources

Resource Centres
4th Asia Pacific RTI Forum Challenges in the management of RTI and antimicrobial therapies

All # A B C D E F G H I J KL MN OP Q RS T UV WXYZ
Companies

All # A B C D E F G H I J KL MN OP Q RS T UV WXYZ
Diagnoses

All # A B C D E F G H I J KL MN OP Q RS T UV WXYZ

2011 UBM Medica About Us | Terms of Use | Privacy | Subscribe | Contact Us | Affiliated Sites | Security Advisory

Node#1

Viewing: Philippines | Change Region >> Drugs | Images | News & CME | Diagnoses Search
Advanced Search Usage Tips